Patents by Inventor J. Michael Williams

J. Michael Williams has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11081901
    Abstract: Methods, systems, and products describe a car, truck, or other vehicle that charges a battery in a mobile device. The vehicle wirelessly inductively charges the battery based on historical usage.
    Type: Grant
    Filed: August 2, 2019
    Date of Patent: August 3, 2021
    Assignee: AT&T Mobility II LLC
    Inventors: Mark Causey, Adrianne Binh Luu, J. Michael Williams
  • Publication number: 20190356155
    Abstract: Methods, systems, and products describe a car, truck, or other vehicle that charges a battery in a mobile device. The vehicle wirelessly inductively charges the battery based on historical usage.
    Type: Application
    Filed: August 2, 2019
    Publication date: November 21, 2019
    Applicant: AT&T Mobility II LLC
    Inventors: Mark Causey, Adrianne Binh Luu, J. Michael Williams
  • Patent number: 10418843
    Abstract: Methods, systems, and products describe a car, truck, or other vehicle that charges a battery in a mobile device. The vehicle wirelessly inductively charges the battery based on historical usage.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: September 17, 2019
    Assignee: AT&T MOBILITY II LLC
    Inventors: Mark Causey, Adrianne Binh Luu, J. Michael Williams
  • Publication number: 20180145532
    Abstract: Methods, systems, and products describe a car, truck, or other vehicle that charges a battery in a mobile device. The vehicle wirelessly inductively charges the battery based on historical usage.
    Type: Application
    Filed: January 19, 2018
    Publication date: May 24, 2018
    Applicant: AT&T Mobility II LLC
    Inventors: Mark Causey, Adrianne Binh Luu, J. Michael Williams
  • Patent number: 9912189
    Abstract: Methods, systems, and products charge a battery in a mobile device. A calendric pattern describes habitual usage of the mobile device. The battery may thus be charged based on the calendric pattern.
    Type: Grant
    Filed: June 7, 2016
    Date of Patent: March 6, 2018
    Assignee: AT&T MOBILITY II LLC
    Inventors: Mark Causey, Adrianne Binh Luu, J. Michael Williams
  • Publication number: 20160285302
    Abstract: Methods, systems, and products charge a battery in a mobile device. A calendric pattern describes habitual usage of the mobile device. The battery may thus be charged based on the calendric pattern.
    Type: Application
    Filed: June 7, 2016
    Publication date: September 29, 2016
    Applicant: AT&T Mobility II LLC
    Inventors: Mark Causey, Adrianne Binh Luu, J. Michael Williams
  • Patent number: 9402914
    Abstract: The present invention provides membrane lytic poly(amido amine) polymers, polyconjugates, compositions and methods for the delivery of oligonucleotides for therapeutic purposes.
    Type: Grant
    Filed: October 3, 2014
    Date of Patent: August 2, 2016
    Assignee: SIRNA THERAPEUTICS, INC.
    Inventors: Marina Busuek, Rubina G. Parmar, Michael Steven Poslusney, Weimin Wang, J. Michael Williams
  • Patent number: 9385557
    Abstract: Methods, systems, and products charge a battery in a mobile device. A calendric pattern describes habitual usage of the mobile device. The battery may thus be charged based on the calendric pattern.
    Type: Grant
    Filed: August 23, 2012
    Date of Patent: July 5, 2016
    Assignee: AT&T MOBILITY II LLC
    Inventors: Mark Causey, Adrianne Binh Luu, J. Michael Williams
  • Publication number: 20150165058
    Abstract: The present invention provides membrane lytic poly(amido amine) polymers, polyconjugates, compositions and methods for the delivery of oligonucleotides for therapeutic purposes.
    Type: Application
    Filed: October 3, 2014
    Publication date: June 18, 2015
    Inventors: Marina Busuek, Rubina G. Parmar, Michael Steven Poslusney, Weimin Wang, J. Michael Williams
  • Patent number: 8987377
    Abstract: The present invention provides poly(amide) polymers, polyconjugates, compositions and methods for the delivery of oligonucleotides for therapeutic purposes.
    Type: Grant
    Filed: November 16, 2011
    Date of Patent: March 24, 2015
    Assignee: Alnylam Pharmaceuticals, Inc.
    Inventors: Stephanie E. Barrett, Marina Busuek, Steven L. Colletti, Robert M. Garbaccio, Erin N. Guidry, Robert A. Kowtoniuk, Jing Liao, Craig A. Parish, Rubina G. Parmar, Tao Pei, Kevin M. Schlosser, David M. Tellers, Sandra C. Tobias, Quang T. Truong, Jacob H. Waldman, Weimin Wang, J. Michael Williams
  • Patent number: 8901101
    Abstract: The present invention provides membrane lytic poly(amido amine) polymers, polyconjugates, compositions and methods for the delivery of oligonucleotides for therapeutic purposes.
    Type: Grant
    Filed: December 12, 2011
    Date of Patent: December 2, 2014
    Assignee: Sirna Therapeutics, Inc.
    Inventors: Marina Busuek, Rubina G. Parmar, Michael Steven Poslusney, Weimin Wang, J. Michael Williams
  • Publication number: 20140055087
    Abstract: Methods, systems, and products charge a battery in a mobile device. A calendric pattern describes habitual usage of the mobile device. The battery may thus be charged based on the calendric pattern.
    Type: Application
    Filed: August 23, 2012
    Publication date: February 27, 2014
    Applicant: AT&T INTELLECTUAL PROPERTY I, L.P.
    Inventors: MARK CAUSEY, ADRIANNE BINH LUU, J. MICHAEL WILLIAMS
  • Publication number: 20130289207
    Abstract: The present invention provides membrane lytic poly(amido amine) polymers, polyconjugates, compositions and methods for the delivery of oligonucleotides for therapeutic purposes.
    Type: Application
    Filed: December 12, 2011
    Publication date: October 31, 2013
    Inventors: Marina Busuek, Rubina G. Parmar, Michael Steven Poslusney, Weimin Wang, J. Michael Williams
  • Publication number: 20130253135
    Abstract: The present invention provides poly(amide) polymers, polyconjugates, compositions and methods for the delivery of oligonucleotides for therapeutic purposes.
    Type: Application
    Filed: November 16, 2011
    Publication date: September 26, 2013
    Inventors: Stephanie E. Barrett, Marina Busuek, Steven L. Colletti, Robert M. Garbaccio, Erin N. Guidry, Robert A. Kowtoniuk, Jing Liao, Craig A. Parish, Rubina G. Parmar, Tao Pei, Kevin M. Schlosser, David M. Tellers, Sandra C. Tobias, Quang T. Truong, Jacob H. Waldman, Weimin Wang, J. Michael Williams
  • Publication number: 20130005797
    Abstract: The present invention provides endosomolytic poly(amidoamine)disulfide polymers, polyconjugates, compositions and methods for the delivery of oligonucleotides for therapeutic purposes.
    Type: Application
    Filed: March 14, 2011
    Publication date: January 3, 2013
    Inventors: Marina Busuek, Steven L. Colletti, Rubina G. Parmar, Weimin Wang, J. Michael Williams
  • Patent number: 7579487
    Abstract: This invention relates to a process for preparing optically active ?-amino acid substrates which are used to make potent lethal factor (LF) inhibitors for the treatment of anthrax. This invention further relates to a process for synthesis of potent LF-inhibitors for the treatment of anthrax. Specifically, the invention concerns a novel, high-yielding and highly enantioselective asymmetric hydrogenation reaction of a tetrasubstituted ene-sulfonamide acid or ester.
    Type: Grant
    Filed: May 6, 2005
    Date of Patent: August 25, 2009
    Assignee: Merck & Co., Inc.
    Inventors: Spencer D. Dreher, Norihiro Ikemoto, C. Scott Shultz, J. Michael Williams
  • Patent number: 7339054
    Abstract: A process is provided for the preparation of branched-chain ribonucleosides of formula (I): from the 1,2-anhydroderivatives of formula (II). wherein PG is a hydroxyl protecting group, B is a purine or pyrimidine nucleobase, and R1 is C1-6 alkyl. The compounds of formula (I) are inhibitors of HCV polymerase useful in the treatment of HCV infection.
    Type: Grant
    Filed: February 6, 2004
    Date of Patent: March 4, 2008
    Assignee: Merck & Co., Inc.
    Inventors: Feng Xu, Matthew M Bio, Cameron Cowden, Kimberly A. Petrillo, J. Michael Williams, Chunhua Yang, Marjorie See Waters
  • Patent number: 7034167
    Abstract: A novel process is provided for the preparation of ribofuranose sugar derivatives which are useful in the synthesis of branched-chain ribonucleoside inhibitors of HCV polymerase for the treatment of HCV infection. Also provided are useful intermediates obtained from the instant process.
    Type: Grant
    Filed: December 5, 2003
    Date of Patent: April 25, 2006
    Assignee: Merck & Co., Inc.
    Inventors: Kimberly A. Savary, Zhiguo J. Song, J. Michael Williams, Feng Xu
  • Publication number: 20040175808
    Abstract: A novel process is provided for the preparation of ribofuranose sugar derivatives which are useful in the synthesis of branched-chain ribonucleoside inhibitors of HCV polymerase for the treatment of HCV infection. Also provided are useful intermediates obtained from the instant process.
    Type: Application
    Filed: December 5, 2003
    Publication date: September 9, 2004
    Inventors: Kimberly A. Savary, Zhiguo J. Song, J. Michael Williams, Feng Xu
  • Publication number: 20030073730
    Abstract: A class of amino-isoxazolidone compounds is described for use in treatment of memory impairment associated with Traumatic Brain Injury (“TBI”). Preferred compounds of this class are D-cycloserine and its prodrugs.
    Type: Application
    Filed: October 16, 2002
    Publication date: April 17, 2003
    Applicant: G.D. Searle & Co.
    Inventors: Daniel T. Fakouhi, Robert L. Herting, J. Michael Williams